Open access
Open access
Powered by Google Translator Translator

General Hematology

Consensus Paper: Diagnosis and treat-to-target management of macrophage activation syndrome in children.

24 Jun, 2022 | 11:13h | UTC

Egyptian evidence-based consensus on clinical practice guidelines for the diagnosis and treat-to-target management of macrophage activation syndrome in children – Egyptian Rheumatology and Rehabilitation

 


M-A: Intravenous iron vs. oral iron vs. no iron with or without erythropoiesis‐ stimulating agents for cancer patients with anemia.

23 Jun, 2022 | 10:10h | UTC

Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis – Cochrane Library

Summary: Which combinations of medicines are best for the prevention and treatment of anaemia in people with cancer? – Cochrane Library

 


Analysis of thromboembolic and thrombocytopenic events after the AstraZeneca, Pfizer, and Moderna COVID-19 vaccines in 3 Nordic countries.

15 Jun, 2022 | 11:17h | UTC

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries – JAMA Network Open

 


Cohort Study: Mortality among patients undergoing blood transfusion in relation to donor sex and parity.

14 Jun, 2022 | 10:56h | UTC

Mortality Among Patients Undergoing Blood Transfusion in Relation to Donor Sex and Parity: A Natural Experiment – JAMA Internal Medicine

News Release: Red blood cell units from female blood donors do not increase risk of death of transfused patients – Karolinska Institutet

 


BSH guideline for the hematological management of major hemorrhage.

13 Jun, 2022 | 10:53h | UTC

A guideline for the haematological management of major haemorrhage: a British Society for Haematology Guideline – British Journal of Haematology

 


Systematic Review: Evidence-based perioperative diagnosis and management of pulmonary embolism.

9 Jun, 2022 | 10:34h | UTC

Evidence-based perioperative diagnosis and management of pulmonary embolism: A systematic review – Annals of Medicine and Surgery

 


Brief Review: Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.

6 Jun, 2022 | 10:55h | UTC

Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery – American Journal of Medicine

 


BSH Guidelines for thrombophilia testing.

2 Jun, 2022 | 11:28h | UTC

Guidelines for thrombophilia testing: A British Society for Haematology guideline

 


NIH Updated Guideline: Antithrombotic therapy in patients with COVID-19.

2 Jun, 2022 | 11:25h | UTC

Antithrombotic Therapy in Patients With COVID-19 – National Institutes of Health

 


BIOIRON Society recommends new classification of hemochromatosis.

24 May, 2022 | 08:09h | UTC

News Release: BIOIRON Society Recommends New Classification of Hemochromatosis – ASH Clinical News

See Guidance: Hemochromatosis classification: update and recommendations by the BIOIRON Society – Blood

 


Review: Role of direct oral anticoagulants for post-operative venous thromboembolism prophylaxis.

18 May, 2022 | 10:46h | UTC

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis – European Cardiovascular Review

 

Commentary on Twitter

Under a CC-BY-NC 4.0 license

 


Guideline Synopsis: Antithrombotic therapy for venous thromboembolism.

17 May, 2022 | 11:12h | UTC

Antithrombotic Therapy for Venous Thromboembolism – JAMA (free for a limited period)

Original Guideline: Antithrombotic Therapy for VTE Disease

Second Update of the CHEST Guideline and Expert Panel Report

 


Cohort Study: Venous or arterial thrombosis and deaths among COVID-19 cases.

17 May, 2022 | 11:02h | UTC

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study – The Lancet Infectious Diseases

Invited Commentary: Risk of arterial and venous thromboses after COVID-19 – The Lancet Infectious Diseases

News Release: COVID-19’s high blood clot risk – University of Oxford

 

Commentary on Twitter

Under a Creative Commons Attribution (CC BY 4.0) license

 


Cohort Study: Sustainability of a clinical decision support intervention for outpatient care for emergency department patients with acute pulmonary embolism.

17 May, 2022 | 10:44h | UTC

Sustainability of a Clinical Decision Support Intervention for Outpatient Care for Emergency Department Patients With Acute Pulmonary Embolism – JAMA Network Open

Related: Outpatient versus inpatient treatment for acute pulmonary embolism – Cochrane Library

 

Commentary on Twitter

 


M-A: Direct oral anticoagulants not as effective as vitamin K antagonists in patients with antiphospholipid syndrome.

13 May, 2022 | 10:43h | UTC

Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis – RMD Open

 


Review: Hemophagocytic Lymphohistiocytosis in patients with HIV.

11 May, 2022 | 10:47h | UTC

A Review of Hemophagocytic Lymphohistiocytosis in Patients With HIV – Open Forum Infectious Diseases

 


Point/Counterpoint: Should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19?

3 May, 2022 | 11:04h | UTC

POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes – CHEST

COUNTERPOINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? No – CHEST

See also: Rebuttal From Dr Tritschler et al – CHEST

Related:

Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

 


National, regional, and global estimates of anemia by severity in women and children for 2000–19.

20 Apr, 2022 | 09:25h | UTC

National, regional, and global estimates of anaemia by severity in women and children for 2000–19: a pooled analysis of population-representative data – The Lancet Global Health

Invited Commentary: Sustainable Development Goals for anaemia: 20 years later, where are we now? – The Lancet Global Health

 


Phase 1–2 clinical trial: Rilzabrutinib, an oral BTK inhibitor, in immune thrombocytopenia.

19 Apr, 2022 | 01:35h | UTC

Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Rilzabrutinib for blood disorder shows promise in phase 1–2 clinical trial – Massachusetts General Hospital

 

Commentary on Twitter

 


RCT: Mitapivat vs. placebo for Pyruvate Kinase Deficiency.

18 Apr, 2022 | 10:13h | UTC

Mitapivat versus Placebo for Pyruvate Kinase Deficiency – New England Journal of Medicine

 


Cohort Study: Non-O blood type is associated with increased risk of venous thromboembolism in patients with cancer.

14 Apr, 2022 | 08:29h | UTC

ABO blood group type and risk of venous thromboembolism in patients with cancer – Blood Advances (link to abstract – $ for full-text)

 


Review: Cutaneous manifestations of monoclonal gammopathy.

14 Apr, 2022 | 08:21h | UTC

Cutaneous manifestations of monoclonal gammopathy – Blood Cancer Journal

 


M-A: Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia.

8 Apr, 2022 | 10:50h | UTC

Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis – International Journal of Infectious Diseases

Related:

Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.

Review: Vaccine-induced immune thrombotic thrombocytopenia.

Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.

Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.

Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis.

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.

Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (several articles and resources on the subject)

 


Study finds increased risk of pulmonary embolism up to 110 days after COVID-19.

7 Apr, 2022 | 10:06h | UTC

Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study – The BMJ

News Release: Study finds increased risk of serious blood clots up to six months after COVID-19 – BMJ

Editorial: Thromboembolism and bleeding after covid-19

Commentary: Covid: Blood clot risk higher for six months after having virus – BBC

 


M-A: Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives.

6 Apr, 2022 | 10:55h | UTC

Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis – Journal of Thrombosis and Haemostasis

 


Stay Updated in Your Specialty

No spam, just news.